Our results clearly demonstrated that, in FPN1-knockout myeloma cells, Nrf2 partially restored the intracellular iron and ROS levels in response to iron deprivation, following brusatol treatment. This evidence concerns the gene SLC40A1 and plasma cell myeloma.